Delcath Systems, Inc. (DCTH)
NASDAQ: DCTH · Real-Time Price · USD
12.79
-0.36 (-2.74%)
Mar 31, 2025, 1:11 PM EDT - Market open
Delcath Systems Revenue
In the year 2024, Delcath Systems had annual revenue of $37.21M with 1,701.69% growth. Delcath Systems had revenue of $15.10M in the quarter ending December 31, 2024, with 2,701.48% growth.
Revenue (ttm)
$37.21M
Revenue Growth
+1,701.69%
P/S Ratio
10.08
Revenue / Employee
$387,552
Employees
96
Market Cap
427.23M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 37.21M | 35.14M | 1,701.69% |
| Dec 31, 2023 | 2.07M | -654.00K | -24.05% |
| Dec 31, 2022 | 2.72M | -836.00K | -23.52% |
| Dec 31, 2021 | 3.56M | 1.91M | 115.98% |
| Dec 31, 2020 | 1.65M | 66.00K | 4.18% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
DCTH News
- 6 days ago - Delcath Systems to Participate at the Canaccord Genuity Horizons in Oncology Virtual Conference - Business Wire
- 16 days ago - Delcath Systems, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 24 days ago - Delcath Systems, Inc. (DCTH) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 25 days ago - Delcath Systems Reports Fourth Quarter and Full Year 2024 Results - Business Wire
- 5 weeks ago - Delcath Systems to Host Fourth Quarter and Full Year 2024 Earnings Call - Business Wire
- 6 weeks ago - Delcath Systems Announces Update to National Comprehensive Cancer Network Clinical Practice Guidelines for the Treatment of Metastatic Uveal Melanoma - Business Wire
- 2 months ago - Delcath Systems to Participate at the BTIG Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Business Wire
- 2 months ago - Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results - Business Wire